Skip to content

FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context

Impact of the Syndromic PCR System FilmArray on Management of ICU Patients With Severe Pulmonary Disease in the Context of the Covid-19 Pandemic.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04453540
Acronym
FAP-REA
Enrollment
150
Registered
2020-07-01
Start date
2020-07-01
Completion date
2020-08-30
Last updated
2020-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Stewardship, Covid-19, Infectious Disease, Molecular Diagnosis, Pneumonia

Brief summary

The research aims to determine the impact of a syndromic mutiplex PCR assay (FilmArray) on the management of patients hospitalized in ICU for severe respiratory disease. During the SARS-CoV-2 outbreak, the diagnosis of pneumonia has become considerably more complex as the biological, radiological and clinical criteria of covid-19 interfere with the standard criteria for the diagnosis of severe respiratory diseases. Moreover, patients with COVID-19 are at higher risk of developing other associated infections and thus, patients have therefore often been treated with antibiotics, adequately or not, due to difficulty to quickly identify the etiology of their symptoms with conventional methods. In order to improve their treatment, both diagnostic and therapeutic, we set up a new syndromic molecular test in our laboratories to accelerate and improve the pneumonia management and antibiotic stewardship. This research will include 100 to 150 adult patients hospitalized in ICU during the first half of 2020. It will take place within the Nancy University Hospital and the Reims University Hospital, France.

Interventions

DIAGNOSTIC_TESTFilmArray PCR on respiratory samples

Molecular test performed on respiratory samples realized for microbiological routine testing as part of the care

Sponsors

Reims University hospital
CollaboratorOTHER
Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients \> 18 years affiliated to a social security system * Patients who have received complete information about the research and who have not objected to the use of its data * Patients with suspected SARS-Cov-2 infection * Patients for which a FilmArray test has been realized on its respiratory samples between 1st of March and 1st of July 2020.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Therapeutic decision24 h following the FilmArray resultsAntibiotic prescription modification following the FilmArray results as: * No prescription * No change in antibiotic utilization * Antibiotic initiation * Antibiotic escalation * Antibiotic de-escalation * Antibiotic discontinuation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026